paclitaxel has been researched along with Abnormality, Heart in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, HM | 1 |
| Bush, CA; Doshi, AA; Magorien, RD; Mazzaferri, EL; Orsini, AR; Schmidt, WT | 1 |
1 review(s) available for paclitaxel and Abnormality, Heart
| Article | Year |
|---|---|
[Pulmonary vascular remodeling in congenital cardiovascular abnormalities: an eternal topic].
Topics: DNA Damage; Familial Primary Pulmonary Hypertension; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Muscle, Smooth, Vascular; Paclitaxel | 2013 |
1 other study(ies) available for paclitaxel and Abnormality, Heart
| Article | Year |
|---|---|
Drug eluting stent implantation for the treatment of symptomatic myocardial bridging is associated with favorable peri-procedural results and short-term outcomes.
Topics: Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Angiography; Coronary Stenosis; Coronary Vessel Anomalies; Drug Delivery Systems; Female; Heart Defects, Congenital; Humans; Male; Myocardial Infarction; Paclitaxel; Prognosis; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sirolimus; Stents; Survival Analysis; Time Factors; Treatment Outcome; Vascular Patency | 2007 |